Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H7389

HealthSpring

<11 members

2.5

0.0 vs 2026Below the 4 star line

Ask about H7389

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

2 · 2.0 pt to 3★

Medication Adherence for Hypertension (RAS antagonists)

2 · 2.0 pt to 3★

Medication Adherence for Cholesterol (Statins)

2 · 2.0 pt to 3★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan21.11
C17 Plan All-Cause Readmissions3x311%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions147%
C06 Monitoring Physical Activity248%
C15 Reducing the Risk of Falling151%
C02 Colorectal Cancer Screening259%
C01 Breast Cancer Screening161%
C19 Transitions of Care361%
C11 Diabetes Care – Eye Exam271%
C13 Kidney Health Evaluation for Patients with Diabetes472%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.